An expert discusses how gene therapy represents a breakthrough treatment approach for BCG-unresponsive patients, offering ...

Personalized therapy A big breakthrough is being hailed in the world of gene editing, with the first custom-designed treatment using CRISPR technology (CRSP).

A recent eGastroenterology review by Professor Intissar Anan highlights major breakthroughs in transthyretin amyloidosis ...

Vectors, both viral and non-viral, continue to further progress gene therapy for a variety of disease states. With further innovation, the approaches can expand their reach even further.

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) is one of the top strong buy stocks under $5 to buy now. Piper Sandler analyst ...

Texas Children's is pleased to announce that a three-year-old girl has been successfully treated with the first-ever ...

A groundbreaking study may change how doctors treat glioblastoma, one of the deadliest brain cancers. Researchers Virginia ...

The bladder cancer market is projected to reach $16 billion across 8 major markets (8MM) by 2033, driven by new therapies and ...

I have seen so much progress for our community, and when I heard about a potential solution to ongoing prophylaxis treatments ...

With significant hedge fund interest and a share price under $10, Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) secures a spot ...

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) is one of the 13 Best Long-Term Penny Stocks to Buy According to Analysts. In a report released on June 11, Maury Raycroft from Jefferies maintained a Buy ...